Role of Mcpip1 in obesity‐induced hepatic steatosis as determined by myeloid and liver‐specific conditional knockouts
Monocyte chemoattractant protein‐induced protein 1 (MCPIP1, alias Regnase 1) is a negative regulator of inflammation, acting through cleavage of transcripts coding for proinflammatory cytokines and by inhibition of NFκB activity. Moreover, it was demonstrated that MCPIP1 regulates lipid metabolism b...
Gespeichert in:
Veröffentlicht in: | The FEBS journal 2021-11, Vol.288 (22), p.6563-6580 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 6580 |
---|---|
container_issue | 22 |
container_start_page | 6563 |
container_title | The FEBS journal |
container_volume | 288 |
creator | Pydyn, Natalia Żurawek, Dariusz Kozieł, Joanna Kus, Edyta Wojnar‐Lason, Kamila Jasztal, Agnieszka Fu, Mingui Jura, Jolanta Kotlinowski, Jerzy |
description | Monocyte chemoattractant protein‐induced protein 1 (MCPIP1, alias Regnase 1) is a negative regulator of inflammation, acting through cleavage of transcripts coding for proinflammatory cytokines and by inhibition of NFκB activity. Moreover, it was demonstrated that MCPIP1 regulates lipid metabolism both in adipose tissue and in hepatocytes. In this study, we investigated the effects of tissue‐specific Mcpip1 deletion on the regulation of hepatic metabolism and development of nonalcoholic fatty liver disease (NAFLD). We used control Mcpip1fl/fl mice and animals with deletion of Mcpip1 in myeloid leukocytes (Mcpip1fl/flLysMCre) and in hepatocytes (Mcpip1fl/flAlbCre), which were fed chow or a high‐fat diet (HFD) for 12 weeks. Mcpip1fl/flLysMCre mice fed a chow diet were characterized by a significantly reduced hepatic expression of genes regulating lipid and glucose metabolism, which subsequently resulted in low plasma glucose level and dyslipidemia. These animals also displayed systemic inflammation, demonstrated by increased concentrations of cytokines in the plasma and high Tnfa, Il6, IL1b mRNA levels in the liver and brown adipose tissue (BAT). Proinflammatory leukocyte infiltration into BAT, together with low expression of Ucp1 and Ppargc1a, resulted in hypothermia of 22‐week‐old Mcpip1fl/flLysMCre mice. On the other hand, there were no significant changes in phenotype in Mcpip1fl/flAlbCre mice. Although we detected a reduced hepatic expression of genes regulating glucose metabolism and β‐oxidation in these mice, they remained asymptomatic. Upon feeding with a HFD, Mcpip1fl/flLysMCre mice did not develop obesity, glucose intolerance, nor hepatic steatosis, but were characterized by low plasma glucose level and dyslipidemia, along with proinflammatory phenotype. Mcpip1fl/flAlbCre animals, following a HFD, became hypercholesterolemic, but accumulated lipids in the liver at the same level as Mcpip1fl/fl mice, and no changes in the level of soluble factors tested in the plasma were detected. We have demonstrated that Mcpip1 protein plays an important role in the liver homeostasis. Depletion of Mcpip1 in myeloid leukocytes, followed by systemic inflammation, has a more pronounced effect on controlling liver metabolism and homeostasis than the depletion of Mcpip1 in hepatocytes.
Mcpip1 is a RNase that degrades mRNA transcripts involved in inflammation and lipid metabolism. In the present study, we examined the contribution of Mcpip1 to liver metabolism and the |
doi_str_mv | 10.1111/febs.16040 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2535836682</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2597472357</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3930-6740ca3c13edc267e6dee1a7b06e1f7d7433fe586a99f95e4fe440f9205233b3</originalsourceid><addsrcrecordid>eNp90ctO3DAUBmCrAnGZsukDVJbYVEhD7fiWLMtogEpTVYJZdBc59rFqJonTOCnKjkfgGXmSehjKggXe2JK_8-tIP0KfKDmn6Xx1UMVzKgknH9ARVTybcynyvdc3_3WIjmO8I4QJXhQH6JBxInKi-BGabkINODj8w3S-o9i3OFQQ_TA9PTz61o4GLP4NnR68wXEAPYToI9YRWxigb3yb_qsJNxPUwVusW4tr_xf6NB47MN6lORNa6wcfWl3jTRvMJoxD_Ij2na4jnLzcM7S-XK4X1_PVz6vvi2-ruWEFI3OpODGaGcrAmkwqkBaAalURCdQpqzhjDkQudVG4QgB3wDlxRUZExljFZujLLrbrw58R4lA2Phqoa91CGGOZCSZyJmWeJXr6ht6FsU9Lb1WhuMqYUEmd7ZTpQ4w9uLLrfaP7qaSk3PZRbvson_tI-PNL5Fg1YF_p_wISoDtw72uY3okqL5cXt7vQf-skmJE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2597472357</pqid></control><display><type>article</type><title>Role of Mcpip1 in obesity‐induced hepatic steatosis as determined by myeloid and liver‐specific conditional knockouts</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><source>Wiley Online Library (Open Access Collection)</source><source>Free Full-Text Journals in Chemistry</source><creator>Pydyn, Natalia ; Żurawek, Dariusz ; Kozieł, Joanna ; Kus, Edyta ; Wojnar‐Lason, Kamila ; Jasztal, Agnieszka ; Fu, Mingui ; Jura, Jolanta ; Kotlinowski, Jerzy</creator><creatorcontrib>Pydyn, Natalia ; Żurawek, Dariusz ; Kozieł, Joanna ; Kus, Edyta ; Wojnar‐Lason, Kamila ; Jasztal, Agnieszka ; Fu, Mingui ; Jura, Jolanta ; Kotlinowski, Jerzy</creatorcontrib><description>Monocyte chemoattractant protein‐induced protein 1 (MCPIP1, alias Regnase 1) is a negative regulator of inflammation, acting through cleavage of transcripts coding for proinflammatory cytokines and by inhibition of NFκB activity. Moreover, it was demonstrated that MCPIP1 regulates lipid metabolism both in adipose tissue and in hepatocytes. In this study, we investigated the effects of tissue‐specific Mcpip1 deletion on the regulation of hepatic metabolism and development of nonalcoholic fatty liver disease (NAFLD). We used control Mcpip1fl/fl mice and animals with deletion of Mcpip1 in myeloid leukocytes (Mcpip1fl/flLysMCre) and in hepatocytes (Mcpip1fl/flAlbCre), which were fed chow or a high‐fat diet (HFD) for 12 weeks. Mcpip1fl/flLysMCre mice fed a chow diet were characterized by a significantly reduced hepatic expression of genes regulating lipid and glucose metabolism, which subsequently resulted in low plasma glucose level and dyslipidemia. These animals also displayed systemic inflammation, demonstrated by increased concentrations of cytokines in the plasma and high Tnfa, Il6, IL1b mRNA levels in the liver and brown adipose tissue (BAT). Proinflammatory leukocyte infiltration into BAT, together with low expression of Ucp1 and Ppargc1a, resulted in hypothermia of 22‐week‐old Mcpip1fl/flLysMCre mice. On the other hand, there were no significant changes in phenotype in Mcpip1fl/flAlbCre mice. Although we detected a reduced hepatic expression of genes regulating glucose metabolism and β‐oxidation in these mice, they remained asymptomatic. Upon feeding with a HFD, Mcpip1fl/flLysMCre mice did not develop obesity, glucose intolerance, nor hepatic steatosis, but were characterized by low plasma glucose level and dyslipidemia, along with proinflammatory phenotype. Mcpip1fl/flAlbCre animals, following a HFD, became hypercholesterolemic, but accumulated lipids in the liver at the same level as Mcpip1fl/fl mice, and no changes in the level of soluble factors tested in the plasma were detected. We have demonstrated that Mcpip1 protein plays an important role in the liver homeostasis. Depletion of Mcpip1 in myeloid leukocytes, followed by systemic inflammation, has a more pronounced effect on controlling liver metabolism and homeostasis than the depletion of Mcpip1 in hepatocytes.
Mcpip1 is a RNase that degrades mRNA transcripts involved in inflammation and lipid metabolism. In the present study, we examined the contribution of Mcpip1 to liver metabolism and the pathogenesis of NAFLD by comparison of mice with deletion of Mcpip1 in the myeloid leukocytes or in hepatocytes. Depletion of Mcpip1 in myeloid leukocytes, but not in hepatocytes, led to systemic inflammation, lean phenotype, hypoglycemia, dyslipidemia, and hypothermia.</description><identifier>ISSN: 1742-464X</identifier><identifier>EISSN: 1742-4658</identifier><identifier>DOI: 10.1111/febs.16040</identifier><identifier>PMID: 34058074</identifier><language>eng</language><publisher>England: Blackwell Publishing Ltd</publisher><subject>Adipose tissue ; Adipose tissue (brown) ; Animals ; Body fat ; Cytokines ; Deletion ; Depletion ; Diet ; Disease control ; Dyslipidemia ; Fatty liver ; Fatty Liver - metabolism ; Gene expression ; Genes ; Glucose ; Glucose metabolism ; Glucose tolerance ; Hepatocytes ; High fat diet ; Homeostasis ; Hypothermia ; IL-1β ; Inflammation ; Interleukin 1 ; Interleukin 6 ; Intolerance ; Leukocytes ; Lipid metabolism ; Lipids ; Liver ; Liver - metabolism ; Liver diseases ; MCPIP1 ; Metabolism ; Mice ; Mice, Knockout ; Mice, Transgenic ; Monocyte chemoattractant protein ; Monocytes ; Myeloid Cells - metabolism ; NAFLD ; NF-κB protein ; Obesity ; Obesity - metabolism ; Oxidation ; Phenotypes ; Plasma ; Proteins ; Ribonucleases - blood ; Ribonucleases - deficiency ; Ribonucleases - metabolism ; Steatosis</subject><ispartof>The FEBS journal, 2021-11, Vol.288 (22), p.6563-6580</ispartof><rights>2021 The Authors. The published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies</rights><rights>2021 The Authors. The FEBS Journal published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies.</rights><rights>2021. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3930-6740ca3c13edc267e6dee1a7b06e1f7d7433fe586a99f95e4fe440f9205233b3</citedby><cites>FETCH-LOGICAL-c3930-6740ca3c13edc267e6dee1a7b06e1f7d7433fe586a99f95e4fe440f9205233b3</cites><orcidid>0000-0002-9145-1979</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Ffebs.16040$$EPDF$$P50$$Gwiley$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Ffebs.16040$$EHTML$$P50$$Gwiley$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,1417,1433,27924,27925,45574,45575,46409,46833</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34058074$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pydyn, Natalia</creatorcontrib><creatorcontrib>Żurawek, Dariusz</creatorcontrib><creatorcontrib>Kozieł, Joanna</creatorcontrib><creatorcontrib>Kus, Edyta</creatorcontrib><creatorcontrib>Wojnar‐Lason, Kamila</creatorcontrib><creatorcontrib>Jasztal, Agnieszka</creatorcontrib><creatorcontrib>Fu, Mingui</creatorcontrib><creatorcontrib>Jura, Jolanta</creatorcontrib><creatorcontrib>Kotlinowski, Jerzy</creatorcontrib><title>Role of Mcpip1 in obesity‐induced hepatic steatosis as determined by myeloid and liver‐specific conditional knockouts</title><title>The FEBS journal</title><addtitle>FEBS J</addtitle><description>Monocyte chemoattractant protein‐induced protein 1 (MCPIP1, alias Regnase 1) is a negative regulator of inflammation, acting through cleavage of transcripts coding for proinflammatory cytokines and by inhibition of NFκB activity. Moreover, it was demonstrated that MCPIP1 regulates lipid metabolism both in adipose tissue and in hepatocytes. In this study, we investigated the effects of tissue‐specific Mcpip1 deletion on the regulation of hepatic metabolism and development of nonalcoholic fatty liver disease (NAFLD). We used control Mcpip1fl/fl mice and animals with deletion of Mcpip1 in myeloid leukocytes (Mcpip1fl/flLysMCre) and in hepatocytes (Mcpip1fl/flAlbCre), which were fed chow or a high‐fat diet (HFD) for 12 weeks. Mcpip1fl/flLysMCre mice fed a chow diet were characterized by a significantly reduced hepatic expression of genes regulating lipid and glucose metabolism, which subsequently resulted in low plasma glucose level and dyslipidemia. These animals also displayed systemic inflammation, demonstrated by increased concentrations of cytokines in the plasma and high Tnfa, Il6, IL1b mRNA levels in the liver and brown adipose tissue (BAT). Proinflammatory leukocyte infiltration into BAT, together with low expression of Ucp1 and Ppargc1a, resulted in hypothermia of 22‐week‐old Mcpip1fl/flLysMCre mice. On the other hand, there were no significant changes in phenotype in Mcpip1fl/flAlbCre mice. Although we detected a reduced hepatic expression of genes regulating glucose metabolism and β‐oxidation in these mice, they remained asymptomatic. Upon feeding with a HFD, Mcpip1fl/flLysMCre mice did not develop obesity, glucose intolerance, nor hepatic steatosis, but were characterized by low plasma glucose level and dyslipidemia, along with proinflammatory phenotype. Mcpip1fl/flAlbCre animals, following a HFD, became hypercholesterolemic, but accumulated lipids in the liver at the same level as Mcpip1fl/fl mice, and no changes in the level of soluble factors tested in the plasma were detected. We have demonstrated that Mcpip1 protein plays an important role in the liver homeostasis. Depletion of Mcpip1 in myeloid leukocytes, followed by systemic inflammation, has a more pronounced effect on controlling liver metabolism and homeostasis than the depletion of Mcpip1 in hepatocytes.
Mcpip1 is a RNase that degrades mRNA transcripts involved in inflammation and lipid metabolism. In the present study, we examined the contribution of Mcpip1 to liver metabolism and the pathogenesis of NAFLD by comparison of mice with deletion of Mcpip1 in the myeloid leukocytes or in hepatocytes. Depletion of Mcpip1 in myeloid leukocytes, but not in hepatocytes, led to systemic inflammation, lean phenotype, hypoglycemia, dyslipidemia, and hypothermia.</description><subject>Adipose tissue</subject><subject>Adipose tissue (brown)</subject><subject>Animals</subject><subject>Body fat</subject><subject>Cytokines</subject><subject>Deletion</subject><subject>Depletion</subject><subject>Diet</subject><subject>Disease control</subject><subject>Dyslipidemia</subject><subject>Fatty liver</subject><subject>Fatty Liver - metabolism</subject><subject>Gene expression</subject><subject>Genes</subject><subject>Glucose</subject><subject>Glucose metabolism</subject><subject>Glucose tolerance</subject><subject>Hepatocytes</subject><subject>High fat diet</subject><subject>Homeostasis</subject><subject>Hypothermia</subject><subject>IL-1β</subject><subject>Inflammation</subject><subject>Interleukin 1</subject><subject>Interleukin 6</subject><subject>Intolerance</subject><subject>Leukocytes</subject><subject>Lipid metabolism</subject><subject>Lipids</subject><subject>Liver</subject><subject>Liver - metabolism</subject><subject>Liver diseases</subject><subject>MCPIP1</subject><subject>Metabolism</subject><subject>Mice</subject><subject>Mice, Knockout</subject><subject>Mice, Transgenic</subject><subject>Monocyte chemoattractant protein</subject><subject>Monocytes</subject><subject>Myeloid Cells - metabolism</subject><subject>NAFLD</subject><subject>NF-κB protein</subject><subject>Obesity</subject><subject>Obesity - metabolism</subject><subject>Oxidation</subject><subject>Phenotypes</subject><subject>Plasma</subject><subject>Proteins</subject><subject>Ribonucleases - blood</subject><subject>Ribonucleases - deficiency</subject><subject>Ribonucleases - metabolism</subject><subject>Steatosis</subject><issn>1742-464X</issn><issn>1742-4658</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>WIN</sourceid><sourceid>EIF</sourceid><recordid>eNp90ctO3DAUBmCrAnGZsukDVJbYVEhD7fiWLMtogEpTVYJZdBc59rFqJonTOCnKjkfgGXmSehjKggXe2JK_8-tIP0KfKDmn6Xx1UMVzKgknH9ARVTybcynyvdc3_3WIjmO8I4QJXhQH6JBxInKi-BGabkINODj8w3S-o9i3OFQQ_TA9PTz61o4GLP4NnR68wXEAPYToI9YRWxigb3yb_qsJNxPUwVusW4tr_xf6NB47MN6lORNa6wcfWl3jTRvMJoxD_Ij2na4jnLzcM7S-XK4X1_PVz6vvi2-ruWEFI3OpODGaGcrAmkwqkBaAalURCdQpqzhjDkQudVG4QgB3wDlxRUZExljFZujLLrbrw58R4lA2Phqoa91CGGOZCSZyJmWeJXr6ht6FsU9Lb1WhuMqYUEmd7ZTpQ4w9uLLrfaP7qaSk3PZRbvson_tI-PNL5Fg1YF_p_wISoDtw72uY3okqL5cXt7vQf-skmJE</recordid><startdate>202111</startdate><enddate>202111</enddate><creator>Pydyn, Natalia</creator><creator>Żurawek, Dariusz</creator><creator>Kozieł, Joanna</creator><creator>Kus, Edyta</creator><creator>Wojnar‐Lason, Kamila</creator><creator>Jasztal, Agnieszka</creator><creator>Fu, Mingui</creator><creator>Jura, Jolanta</creator><creator>Kotlinowski, Jerzy</creator><general>Blackwell Publishing Ltd</general><scope>24P</scope><scope>WIN</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>7TM</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-9145-1979</orcidid></search><sort><creationdate>202111</creationdate><title>Role of Mcpip1 in obesity‐induced hepatic steatosis as determined by myeloid and liver‐specific conditional knockouts</title><author>Pydyn, Natalia ; Żurawek, Dariusz ; Kozieł, Joanna ; Kus, Edyta ; Wojnar‐Lason, Kamila ; Jasztal, Agnieszka ; Fu, Mingui ; Jura, Jolanta ; Kotlinowski, Jerzy</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3930-6740ca3c13edc267e6dee1a7b06e1f7d7433fe586a99f95e4fe440f9205233b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adipose tissue</topic><topic>Adipose tissue (brown)</topic><topic>Animals</topic><topic>Body fat</topic><topic>Cytokines</topic><topic>Deletion</topic><topic>Depletion</topic><topic>Diet</topic><topic>Disease control</topic><topic>Dyslipidemia</topic><topic>Fatty liver</topic><topic>Fatty Liver - metabolism</topic><topic>Gene expression</topic><topic>Genes</topic><topic>Glucose</topic><topic>Glucose metabolism</topic><topic>Glucose tolerance</topic><topic>Hepatocytes</topic><topic>High fat diet</topic><topic>Homeostasis</topic><topic>Hypothermia</topic><topic>IL-1β</topic><topic>Inflammation</topic><topic>Interleukin 1</topic><topic>Interleukin 6</topic><topic>Intolerance</topic><topic>Leukocytes</topic><topic>Lipid metabolism</topic><topic>Lipids</topic><topic>Liver</topic><topic>Liver - metabolism</topic><topic>Liver diseases</topic><topic>MCPIP1</topic><topic>Metabolism</topic><topic>Mice</topic><topic>Mice, Knockout</topic><topic>Mice, Transgenic</topic><topic>Monocyte chemoattractant protein</topic><topic>Monocytes</topic><topic>Myeloid Cells - metabolism</topic><topic>NAFLD</topic><topic>NF-κB protein</topic><topic>Obesity</topic><topic>Obesity - metabolism</topic><topic>Oxidation</topic><topic>Phenotypes</topic><topic>Plasma</topic><topic>Proteins</topic><topic>Ribonucleases - blood</topic><topic>Ribonucleases - deficiency</topic><topic>Ribonucleases - metabolism</topic><topic>Steatosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pydyn, Natalia</creatorcontrib><creatorcontrib>Żurawek, Dariusz</creatorcontrib><creatorcontrib>Kozieł, Joanna</creatorcontrib><creatorcontrib>Kus, Edyta</creatorcontrib><creatorcontrib>Wojnar‐Lason, Kamila</creatorcontrib><creatorcontrib>Jasztal, Agnieszka</creatorcontrib><creatorcontrib>Fu, Mingui</creatorcontrib><creatorcontrib>Jura, Jolanta</creatorcontrib><creatorcontrib>Kotlinowski, Jerzy</creatorcontrib><collection>Wiley Online Library (Open Access Collection)</collection><collection>Wiley Online Library (Open Access Collection)</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>The FEBS journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pydyn, Natalia</au><au>Żurawek, Dariusz</au><au>Kozieł, Joanna</au><au>Kus, Edyta</au><au>Wojnar‐Lason, Kamila</au><au>Jasztal, Agnieszka</au><au>Fu, Mingui</au><au>Jura, Jolanta</au><au>Kotlinowski, Jerzy</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Role of Mcpip1 in obesity‐induced hepatic steatosis as determined by myeloid and liver‐specific conditional knockouts</atitle><jtitle>The FEBS journal</jtitle><addtitle>FEBS J</addtitle><date>2021-11</date><risdate>2021</risdate><volume>288</volume><issue>22</issue><spage>6563</spage><epage>6580</epage><pages>6563-6580</pages><issn>1742-464X</issn><eissn>1742-4658</eissn><abstract>Monocyte chemoattractant protein‐induced protein 1 (MCPIP1, alias Regnase 1) is a negative regulator of inflammation, acting through cleavage of transcripts coding for proinflammatory cytokines and by inhibition of NFκB activity. Moreover, it was demonstrated that MCPIP1 regulates lipid metabolism both in adipose tissue and in hepatocytes. In this study, we investigated the effects of tissue‐specific Mcpip1 deletion on the regulation of hepatic metabolism and development of nonalcoholic fatty liver disease (NAFLD). We used control Mcpip1fl/fl mice and animals with deletion of Mcpip1 in myeloid leukocytes (Mcpip1fl/flLysMCre) and in hepatocytes (Mcpip1fl/flAlbCre), which were fed chow or a high‐fat diet (HFD) for 12 weeks. Mcpip1fl/flLysMCre mice fed a chow diet were characterized by a significantly reduced hepatic expression of genes regulating lipid and glucose metabolism, which subsequently resulted in low plasma glucose level and dyslipidemia. These animals also displayed systemic inflammation, demonstrated by increased concentrations of cytokines in the plasma and high Tnfa, Il6, IL1b mRNA levels in the liver and brown adipose tissue (BAT). Proinflammatory leukocyte infiltration into BAT, together with low expression of Ucp1 and Ppargc1a, resulted in hypothermia of 22‐week‐old Mcpip1fl/flLysMCre mice. On the other hand, there were no significant changes in phenotype in Mcpip1fl/flAlbCre mice. Although we detected a reduced hepatic expression of genes regulating glucose metabolism and β‐oxidation in these mice, they remained asymptomatic. Upon feeding with a HFD, Mcpip1fl/flLysMCre mice did not develop obesity, glucose intolerance, nor hepatic steatosis, but were characterized by low plasma glucose level and dyslipidemia, along with proinflammatory phenotype. Mcpip1fl/flAlbCre animals, following a HFD, became hypercholesterolemic, but accumulated lipids in the liver at the same level as Mcpip1fl/fl mice, and no changes in the level of soluble factors tested in the plasma were detected. We have demonstrated that Mcpip1 protein plays an important role in the liver homeostasis. Depletion of Mcpip1 in myeloid leukocytes, followed by systemic inflammation, has a more pronounced effect on controlling liver metabolism and homeostasis than the depletion of Mcpip1 in hepatocytes.
Mcpip1 is a RNase that degrades mRNA transcripts involved in inflammation and lipid metabolism. In the present study, we examined the contribution of Mcpip1 to liver metabolism and the pathogenesis of NAFLD by comparison of mice with deletion of Mcpip1 in the myeloid leukocytes or in hepatocytes. Depletion of Mcpip1 in myeloid leukocytes, but not in hepatocytes, led to systemic inflammation, lean phenotype, hypoglycemia, dyslipidemia, and hypothermia.</abstract><cop>England</cop><pub>Blackwell Publishing Ltd</pub><pmid>34058074</pmid><doi>10.1111/febs.16040</doi><tpages>18</tpages><orcidid>https://orcid.org/0000-0002-9145-1979</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1742-464X |
ispartof | The FEBS journal, 2021-11, Vol.288 (22), p.6563-6580 |
issn | 1742-464X 1742-4658 |
language | eng |
recordid | cdi_proquest_miscellaneous_2535836682 |
source | MEDLINE; Access via Wiley Online Library; Wiley Online Library (Open Access Collection); Free Full-Text Journals in Chemistry |
subjects | Adipose tissue Adipose tissue (brown) Animals Body fat Cytokines Deletion Depletion Diet Disease control Dyslipidemia Fatty liver Fatty Liver - metabolism Gene expression Genes Glucose Glucose metabolism Glucose tolerance Hepatocytes High fat diet Homeostasis Hypothermia IL-1β Inflammation Interleukin 1 Interleukin 6 Intolerance Leukocytes Lipid metabolism Lipids Liver Liver - metabolism Liver diseases MCPIP1 Metabolism Mice Mice, Knockout Mice, Transgenic Monocyte chemoattractant protein Monocytes Myeloid Cells - metabolism NAFLD NF-κB protein Obesity Obesity - metabolism Oxidation Phenotypes Plasma Proteins Ribonucleases - blood Ribonucleases - deficiency Ribonucleases - metabolism Steatosis |
title | Role of Mcpip1 in obesity‐induced hepatic steatosis as determined by myeloid and liver‐specific conditional knockouts |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T05%3A51%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Role%20of%20Mcpip1%20in%20obesity%E2%80%90induced%20hepatic%20steatosis%20as%20determined%20by%20myeloid%20and%20liver%E2%80%90specific%20conditional%20knockouts&rft.jtitle=The%20FEBS%20journal&rft.au=Pydyn,%20Natalia&rft.date=2021-11&rft.volume=288&rft.issue=22&rft.spage=6563&rft.epage=6580&rft.pages=6563-6580&rft.issn=1742-464X&rft.eissn=1742-4658&rft_id=info:doi/10.1111/febs.16040&rft_dat=%3Cproquest_cross%3E2597472357%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2597472357&rft_id=info:pmid/34058074&rfr_iscdi=true |